Editorial
doi: 10.1016/j.jacc.2020.08.004.
"Cholesterol-Years" for ASCVD Risk Prediction and Treatment
Affiliations
- PMID: 32972527
- DOI: 10.1016/j.jacc.2020.08.004
Item in Clipboard
Editorial
"Cholesterol-Years" for ASCVD Risk Prediction and Treatment
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: CARDIA; cardiovascular disease; cholesterol lowering; cholesterol-years; coronary heart disease; low-density lipoprotein; preventive cardiology.
Comment on
-
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk.J Am Coll Cardiol. 2020 Sep 29;76(13):1507-1516. doi: 10.1016/j.jacc.2020.07.059. J Am Coll Cardiol. 2020. PMID: 32972526
Similar articles
-
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29. Circulation. 2015. PMID: 26224808 Free PMC article.
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.Circulation. 2019 Nov 5;140(19):1578-1589. doi: 10.1161/CIRCULATIONAHA.119.042551. Epub 2019 Sep 2. Circulation. 2019. PMID: 31475572 Free PMC article. Clinical Trial.
-
Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.J Am Heart Assoc. 2017 May 4;6(5):e005205. doi: 10.1161/JAHA.116.005205. J Am Heart Assoc. 2017. PMID: 28473405 Free PMC article.
-
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y. Curr Diab Rep. 2019. PMID: 31754844 Review.
-
Recent AHA/ACC guidelines on cholesterol management expands the role of the clinical laboratory.Clin Chim Acta. 2019 Aug;495:82-84. doi: 10.1016/j.cca.2019.04.002. Epub 2019 Apr 3. Clin Chim Acta. 2019. PMID: 30953613 Review.
Cited by
-
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids.Cardiovasc Drugs Ther. 2024 Feb 16. doi: 10.1007/s10557-023-07519-z. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38363478 Review.
-
Cholesterol associated genetic risk score and acute coronary syndrome in Czech males.Mol Biol Rep. 2024 Jan 22;51(1):164. doi: 10.1007/s11033-023-09128-3. Mol Biol Rep. 2024. PMID: 38252350 Free PMC article.
-
LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy.Adv Ther. 2024 Jan;41(1):451-463. doi: 10.1007/s12325-023-02716-6. Epub 2023 Nov 21. Adv Ther. 2024. PMID: 37989909 Free PMC article.
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress.Curr Atheroscler Rep. 2023 Dec;25(12):965-978. doi: 10.1007/s11883-023-01164-5. Epub 2023 Nov 17. Curr Atheroscler Rep. 2023. PMID: 37975955 Review.
-
Obesity-Status-Linked Affecting Factors of Dyslipidemia in Korean Young-Adult Men: Based on the Korea National Health and Nutrition Examination Survey (2019-2021).Healthcare (Basel). 2023 Jul 13;11(14):2015. doi: 10.3390/healthcare11142015. Healthcare (Basel). 2023. PMID: 37510456 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
